Phenanthriplatin(iv) conjugated multifunctional up-converting nanoparticles for drug delivery and biomedical imaging. Issue 31 (24th July 2018)

• Record Type: Journal Article
• Authors: Teng, Bo; Han, Yanqiu; Zhang, Xinyang; Xiao, Haihua; Yu, Chang; Li, HeJie; Cheng, Ziyong; Jin, Dayong; Wong, Ka-Leung; Ma, Ping'an; Lin, Jun
• Is Part Of: Journal of materials chemistry. Volume 6:Issue 31(2018)
• Page Start: 5059
• Page End: 5068
• Publication Date: 2018-07-24
• Subjects: Materials -- Periodicals; Chemistry, Analytic -- Periodicals; Biomedical materials -- Research -- Periodicals; 543.0284
• DOI: 10.1039/c8tb01034j
• Languages: English
• ISSNs: 2050-750X

Abstract

Abstract : Platinum-based drugs cisplatin, carboplatin, and oxaliplatin are widely used in the clinical treatment of cancer. Abstract : Platinum-based drugs cisplatin, carboplatin, and oxaliplatin are widely used in the clinical treatment of cancer. However, the clinical applications of platinum-based drugs are greatly limited by the side-effects, lack of selectivity, fast blood clearance, and intrinsic or acquired drug resistance. In this study, we report an anticancer drug delivery system based on phenanthriplatin(iv ) (Phen-Pt(iv ))-conjugated NaGdF4 :Yb 3+ /Er 3+ nanoparticles. The upconversion luminescent NaGdF4 :Yb 3+ /Er 3+ nanoparticles (UCNPs) were further modified with polyethyleneimine (PEI), poly(ethylene glycol) (PEG) and the cancer targeting ligand arginine–glycine–aspartic peptide (RGD), resulting in the formation of water-dispersible and biologically functionalized UCNP@PEI–Phen-Pt–PEG–RGD nanoparticles. The Phen-Pt-conjugated UCNP@PEI–Phen-Pt–PEG–RGD nanoparticles exhibited an obvious cytotoxic effect on Hep-2 cells (Human Laryngeal Carcinoma cell line) via MTT assay. Meanwhile, the endocytosis process of Phen-Pt-conjugated NaGdF4 :Yb 3+ /Er 3+ nanoparticles by Hep-2 cells was demonstrated through flow cytometry and ICP-MS. In addition, the upconversion luminescence image of UCNP@PEI–Phen-Pt–PEG–RGD taken up by cells shows green emission under 980 nm infrared laser excitation, making the UCNP@PEI–Phen-Pt–PEG–RGD nanocomposites promising candidates as bioimaging agents. Moreover, these UCNPs were further explored for in vitro and in vivo T 1 -weighted magnetic resonance (MR) imaging. The in vivo experiments on mice also confirmed that the Phen-Pt(iv )-conjugated nanoparticles have a relatively high tumor inhibition rate. These results indicate that the multifunctional nanoparticles can be expected to be a platform for simultaneous imaging and cancer therapeutic applications.